Get the Stockscreener App
1.92
8.57%
-0.18
After Hours:
1.92
Finch Therapeutics Group Inc Stock (FNCH) Forecast
The Finch Therapeutics Group Inc (FNCH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.465, representing a -75.78% decrease from the current price of $1.92. The highest analyst price target is $0.8199, and the lowest is $0.1101.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FNCH Price Target
Average 4.4187
(+130.14% Upside)
Is Finch Therapeutics Group Inc (FNCH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.60 | Neutral |
| STOCH(9,6) | 9.8087 | Buy |
| STOCHRSI(14) | 21.31 | Neutral |
| MACD(12,26) | -0.1306 | Sell |
| ADX(14) | 21.63 | Neutral |
| William %R | -93.59 | Buy |
| CCI(14) | -79.83 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.071
Sell
|
2.0652
Sell
|
| MA20 |
2.2124
Sell
|
2.1733
Sell
|
| MA50 |
2.416
Sell
|
2.3804
Sell
|
| MA100 |
2.6597
Sell
|
2.7361
Sell
|
| MA200 |
3.8502
Sell
|
2.9143
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, FNCH could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on FNCH, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.6 indicates that FNCH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 9.8087 indicates that FNCH is oversold. This indicates that FNCH price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 21.31 indicates that FNCH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.63 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -79.83 indicates that FNCH is still oversold but not to an extreme extent.
Long-term FNCH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Finch Therapeutics Group Inc financial reports and earnings history, Finch Therapeutics Group Inc (FNCH) stock could reach $13.05 by 2030, $41.92 by 2040 and $77.06 by 2050. See the projected annual prices until 2050 of the Finch Therapeutics Group Inc stock below:
- Finch Therapeutics Group Inc (FNCH) is expected to reach an average price of $40.08 in 2035, with a high prediction of $40.02 and a low estimate of $38.95. This indicates an $1,988% rise from the last recorded price of $1.92.
- Finch Therapeutics Group Inc (FNCH) stock is projected to chart a bullish course in 2040, with an average price target of $41.30, representing an $2,051% surge from its current level. The forecast ranges from a conservative $41.82 to a sky-high $41.92.
- Our analysts predict Finch Therapeutics Group Inc (FNCH) to jump 901.61% by 2045, soaring from $19.68 to an average price of $19.23, potentially reaching $20.30. While $19.68 is the low estimate, the potential upside is significant.
- Finch Therapeutics Group Inc (FNCH) stock is expected to climb by 2050, reaching an average of $78.24, a $3,975% jump from its current level. However, a wide range of estimates exists, with high and low targets of $77.06 and $78.41, respectively, highlighting the market's uncertainty.
Finch Therapeutics Group Inc Stock (FNCH) Year by Year Forecast
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2024
Our forecast for FNCH stock price in 2024 now indicates an average price target of $4.4187 with a high forecast of $8.8364 and a low forecast of $0.00104. The average prediction reflects an increase of +130.14% from the last recorded price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.3519 | $0.1101 | $0.8199 | -29.59% |
| July, 2024 | $2.9287 | $0.1264 | $8.8364 | +52.54% |
| August, 2024 | $1.7052 | $0.1869 | $4.1628 | -11.19% |
| September, 2024 | $1.3416 | $0.2525 | $4.3134 | -30.12% |
| October, 2024 | $3.3622 | $0.039 | $3.8572 | +75.12% |
| November, 2024 | $0.8687 | $0.3263 | $4.5413 | -54.76% |
| December, 2024 | $0.4252 | $0.00104 | $1.5032 | -77.86% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2025
Finch Therapeutics Group Inc Stock (FNCH) is expected to reach an average price of $3.7841 in 2025, with a high prediction of $7.259 and a low estimate of $0.3093. This indicates an +97.09% rise from the last recorded price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.3657 | $0.3093 | $5.5857 | +179.47% |
| February, 2025 | $2.1978 | $0.6919 | $6.114 | +14.47% |
| March, 2025 | $1.7913 | $1.2696 | $0.7713 | -6.70% |
| April, 2025 | $2.1607 | $2.3207 | $1.859 | +12.54% |
| May, 2025 | $3.7143 | $2.0684 | $1.8284 | +93.45% |
| June, 2025 | $5.0278 | $4.4502 | $4.2678 | +161.87% |
| July, 2025 | $7.2072 | $5.2196 | $6.0872 | +275.38% |
| August, 2025 | $7.1508 | $7.4731 | $7.259 | +272.44% |
| September, 2025 | $6.6043 | $6.7643 | $6.9366 | +243.97% |
| October, 2025 | $6.6237 | $6.2719 | $6.2061 | +244.98% |
| November, 2025 | $5.9272 | $6.4672 | $6.5856 | +208.71% |
| December, 2025 | $5.6067 | $6.099 | $5.9308 | +192.01% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2026
The predicted value for Finch Therapeutics Group Inc (FNCH) in 2026 is set at an average of $6.6407. Estimates vary from a peak of $11.30 to a trough of $1.9827, indicating an +245.87% surge from the present price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.3402 | $5.8625 | $6.2643 | +230.22% |
| February, 2026 | $6.5137 | $6.4261 | $6.3837 | +239.26% |
| March, 2026 | $6.6373 | $6.5496 | $6.4673 | +245.69% |
| April, 2026 | $6.8767 | $6.5148 | $6.4542 | +258.16% |
| May, 2026 | $6.4792 | $6.4802 | $6.6826 | +237.46% |
| June, 2026 | $6.2337 | $6.2587 | $6.322 | +224.67% |
| July, 2026 | $6.0431 | $6.0532 | $6.1826 | +214.74% |
| August, 2026 | $5.7738 | $5.7867 | $5.9191 | +200.72% |
| September, 2026 | $5.4685 | $5.4846 | $5.6836 | +184.82% |
| October, 2026 | $5.2701 | $5.2906 | $5.3914 | +174.49% |
| November, 2026 | $3.2168 | $1.9827 | $11.30 | +67.54% |
| December, 2026 | $2.6674 | $2.5354 | $4.3633 | +38.93% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Finch Therapeutics Group Inc (FNCH) is $6.4258, with a high forecast of $12.85 and a low forecast of $0.00318. This indicates an +234.68% increase from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6389 | $1.264 | $3.42 | -14.64% |
| February, 2027 | $1.2604 | $1.0562 | $2.8934 | -34.36% |
| March, 2027 | $0.1491 | $0.00318 | $1.7163 | -92.24% |
| April, 2027 | $0.0024 | $0.3297 | $0.4495 | -99.87% |
| May, 2027 | $0.8439 | $0.0902 | $2.0539 | -56.05% |
| June, 2027 | $0.1245 | $0.0245 | $1.418 | -93.52% |
| July, 2027 | $0.3191 | $0.2214 | $0.5086 | -83.38% |
| August, 2027 | $0.3926 | $0.4608 | $0.1667 | -79.55% |
| September, 2027 | $0.078 | $0.018 | $1.9039 | -95.94% |
| October, 2027 | $0.00444 | $0.0521 | $1.1344 | -99.77% |
| November, 2027 | $11.53 | $0.0527 | $10.89 | +500.59% |
| December, 2027 | $13.04 | $11.66 | $12.85 | +579.18% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2028
In 2028, Finch Therapeutics Group Inc (FNCH) is projected to reach an average price of $10.94, with a high projection of $14.06 and a low estimate of $7.8303. This indicates an +469.99% rise from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $11.94 | $13.14 | $13.80 | +521.73% |
| February, 2028 | $11.28 | $11.56 | $11.84 | +487.73% |
| March, 2028 | $11.90 | $11.47 | $10.97 | +519.96% |
| April, 2028 | $12.03 | $11.91 | $11.36 | +526.58% |
| May, 2028 | $9.5191 | $10.86 | $10.17 | +395.79% |
| June, 2028 | $11.71 | $10.55 | $10.54 | +509.70% |
| July, 2028 | $9.1732 | $10.42 | $10.90 | +377.77% |
| August, 2028 | $7.2321 | $7.8303 | $7.135 | +276.67% |
| September, 2028 | $12.07 | $11.90 | $11.15 | +528.60% |
| October, 2028 | $13.41 | $12.89 | $12.57 | +598.24% |
| November, 2028 | $12.28 | $12.59 | $12.56 | +539.32% |
| December, 2028 | $14.77 | $12.45 | $14.06 | +669.38% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2029
The 2029 price forecast for Finch Therapeutics Group Inc Stock (FNCH) is $15.05 on average, with a high prediction of $16.87 and a low estimate of $13.24. This represents an +684.11% increase from the previous price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.65 | $15.13 | $14.93 | +715.15% |
| February, 2029 | $16.99 | $16.94 | $16.87 | +784.79% |
| March, 2029 | $16.22 | $16.45 | $16.62 | +744.53% |
| April, 2029 | $15.35 | $15.65 | $15.68 | +699.59% |
| May, 2029 | $15.60 | $15.30 | $15.40 | +712.55% |
| June, 2029 | $14.51 | $14.62 | $15.04 | +655.63% |
| July, 2029 | $14.07 | $14.13 | $14.33 | +632.56% |
| August, 2029 | $14.53 | $14.43 | $14.40 | +656.97% |
| September, 2029 | $14.30 | $14.30 | $14.20 | +644.84% |
| October, 2029 | $13.82 | $13.88 | $14.02 | +619.56% |
| November, 2029 | $13.74 | $13.80 | $13.86 | +615.46% |
| December, 2029 | $13.20 | $13.24 | $13.50 | +587.71% |
Finch Therapeutics Group Inc Stock (FNCH) Price Forecast for 2030
Finch Therapeutics Group Inc Stock (FNCH) is expected to reach an average price of $7.2662 in 2030, with a high forecast of $13.05 and a low forecast of $1.4866. This signifies an +278.45% surge from the last price of $1.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.65 | $12.70 | $13.05 | +558.79% |
| February, 2030 | $12.18 | $12.20 | $12.48 | +534.37% |
| March, 2030 | $11.56 | $11.69 | $12.01 | +502.18% |
| April, 2030 | $11.23 | $11.26 | $11.41 | +484.84% |
| May, 2030 | $2.6228 | $3.1339 | $11.09 | +36.60% |
| June, 2030 | $1.1999 | $1.5699 | $1.6263 | -37.51% |
| July, 2030 | $3.1287 | $1.4866 | $1.7387 | +62.95% |
| August, 2030 | $2.9057 | $2.9057 | $2.8305 | +51.34% |
| September, 2030 | $3.5228 | $3.2193 | $2.7522 | +83.48% |
| October, 2030 | $4.1817 | $4.2264 | $4.1817 | +117.79% |
| November, 2030 | $3.8487 | $3.9387 | $3.5687 | +100.45% |
| December, 2030 | $3.5958 | $2.9823 | $3.2099 | +87.28% |
4.27%
2.59%
Cap:
|
Volume (24h):